Exactech to Present at the 2010 Noble Financial Equity Conference on June 7
GAINESVILLE, Fla. – June 2, 2010 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Sixth Annual Noble Financial Equity Conference in Hollywood, Florida. The two-day investor conference will showcase 140 small cap public companies.
GAINESVILLE, Fla. – June 2, 2010 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Sixth Annual Noble Financial Equity Conference in Hollywood, Florida. The two-day investor conference will showcase 140 small cap public companies.
Senior Vice President Bruce Thompson and Chief Financial Officer Jody Phillips will deliver a presentation on Exactech’s market positioning, products, financial performance and strategic direction at 3:30 p.m. ET on Monday, June 7, and will host a question and answer session after the presentation. Thompson and Phillips will also host one-on-one meetings with investors during the two-day conference.
The presentation with streaming video and PowerPoint slides will be webcast live and archived at http://www.hawkassociates.com/profile/exac.cfm and Noble Financial’s conference website at: http://www.nobleresearch.com/ontrack/10.htm. The SilverLight viewer is required (a free download from the presentation link).
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service investment banking boutique focused on small-cap, emerging growth companies. The company has offices in New York, Boston, New Jersey, St Louis and Boca Raton. For additional information, visit: http://www.nobleresearch.com.
About Exactech
Based in Gainesville, Fla., Exactech is celebrating its 25th anniversary developing and marketing orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.
An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Investor contacts
Jody Phillips
Chief Financial Officer
352-377-1140
Julie Marshall or Frank Hawkins
Hawk Associates
305-451-1888
E-mail: exactech@hawkassociates.com.

Stay Connected